Carolinas HealthCare System

Research and Clinical Trials

Breast - Female 

Brief Description PrincipalĀ Investigator
To evaluate whether radiation to the undissected axilla and regional lymph nodes is not inferior to axillary lymph node dissection with radiation to the regional lymph nodes but not to the dissected axilla in terms of invasive breast cancer recurrence-free interval in patients with positive SLN(s) after completion of neoadjuvant chemotherapy
White, Richard Laverne 
This phase II trial studies how well breast-conserving surgery and radiation therapy work in treating patients with multiple ipsilateral breast cancer White, Richard Laverne 
Celgene ABI-007-ST-001 Carrizosa, Daniel Ricardo 
I. To maintain a Childhood Cancer Registry for infants, children, adolescents, and young adults with cancer.

II. To utilize clinical and biological data to help determine eligibility or stratification, based on childhood cancer disease classification schemas, for potential enrollment of research subjects onto Children's Oncology Group (COG) therapeutic clinical trials.

III. To develop a well annotated childhood cancer biobank for current and future research through the collection of biospe
Kaplan, Joel Adam 
To estimate the efficacy of ipatasertib combined with paclitaxel compared with placebo combined with paclitaxel in patients with inoperable locally advanced or metastatic triple negative breast cancer (mTNBC), as measured by progression-free survival (PFS) in all patients and in patients with PTEN-low tumors. Tan, Antoinette Roslyn 
The primary objective is to determine the maximum tolerated dose (MTD) and/or recommended Phase II dose (RP2D) and assess the safety of GDC-0810 in postmenopausal women with locally advanced or metastatic ER+ (HER2-)breast cancer. Tan, Antoinette Roslyn 
The primary efficacy objective is to estimate the efficacy of ipatasertib combined with paclitaxel compared with placebo combined with paclitaxel in patients with early stage TNBC, as measured by local pathology laboratory evaluation of pCR rate within the breast and exilla (ypT0/Tis ypN0) in all patients and in patients with PTEN-low tumors. Fisher, Julie Gottlieb 
Primary Objectives to include: PrimaryTo determine safe and biologically active Phase 2 doses (recommended Phase 2 doses [RP2D]) for JNJ-42756493 in the Part 1 Dose-Escalation Phase; and to evaluate the feasibility of treating a molecularly-defined subset of subjects with non-small-cell lung cancer (NSCLC), small-cell lung cancer (SCLC), breast cancer, and all-comers with solid tumors with JNJ-42756493 at the RP2Ds (Part 3 and 4; Dose-Expansion Phases).
Secondary Objectives to include: To evalu
Chai, Seungjean 
Primary: to compare radioactive seed localization (RSL) and wire-guided localization (WL) based on negative margins in malignant disease where negative margins is defined as no tumor on ink in invasive disease, and greater than or equal to 2mm from the inked margin in non-invasive disease (DCIS).
Secondary: to compare RSL and WL base on the following: total procedure cost, subject satisfaction over time, time from subject consult to operating room, radiologist satisfaction, time in radiology, s
Hadzikadic-Gusic, Lejla 
To evaluate the objective response rate (ORR) to pembrolizumab as 2L+ monotherapy in subjects with PD-L1(+)high centrally confirmed mTNBC, based on RECIST 1.1 as assessed by central radiology review. Tan, Antoinette Roslyn 
This randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery. Radiation therapy uses high-energy x rays to kill tumor cells. It is not yet known whether comprehensive radiation therapy is more effective than standard radiation therapy in treating patients with breast cancer. Sharp, Hadley Jean 
The primary objective is to assess the effect of adjuvant treatment with olaparib on Invasive Disease Free Survival (IDFS). Tan, Antoinette Roslyn 
About Carolinas HealthCare System
Who We Are
Community Benefit
Corporate Financial Information
Diversity & Inclusion
Annual Report
Patient Links
Pay Your Bill
Hospital Pre-Registration
Patient Rights
Financial Assistance
Quality & Value Reports
Join Carolinas HealthCare System
Physician Careers

For Employees
Carolinas Connect
Connect with Us
Watch Carolinas HealthCare on YoutubeFollow Carolinas HealthCare on TwitterLike Carolinas HealthCare on FacebookContact Carolinas HealthCareJoin Carolinas HealthCare on LinkedInGo to our mobile website.